Free Trial

Avadel Pharmaceuticals (AVDL) Earnings Date, Estimates & Call Transcripts

Avadel Pharmaceuticals logo
$11.32 +0.57 (+5.30%)
(As of 01:00 PM ET)

Avadel Pharmaceuticals Latest Earnings Summary

Upcoming Q4
Earnings Date
Mar. 3Estimated
Actual EPS
(Nov. 12)
-$0.03 Beat By $0.03
Consensus EPS
(Nov. 12)
-$0.06

Avadel Pharmaceuticals announced Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.03, which topped analysts' consensus estimates of -$0.06 by $0.03. Quarterly revenue rose 624.6% year-over-year to $50 million, above the consensus estimate of $48.43 million. With a trailing EPS of -$0.79, Avadel Pharmaceuticals' earnings are expected to grow next year, from ($0.48) to $0.53 per share.

AVDL Upcoming Earnings

Avadel Pharmaceuticals' next earnings date is estimated for Monday, March 3, 2025, based off prior year's reporting schedules.

Get Avadel Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avadel Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

AVDL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AVDL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Avadel Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242-$0.31-$0.18-$0.25 
Q2 20243-$0.18-$0.14-$0.16 
Q3 20243-$0.10$0.01-$0.04 
Q4 20243-$0.08$0.03-$0.04 
FY 202411($0.67)($0.28) ($0.48)

Avadel Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/3/2025
(Estimated)
------- 
11/12/2024Q3 2024-$0.06-$0.03+$0.03-$0.03$48.43M$50.00M      
8/8/2024Q2 2024-$0.17-$0.14+$0.03-$0.14$37.47M$41.50M          
5/8/2024Q1 2024-$0.25-$0.30 -$0.05-$0.30$25.89M$27.18M        
3/4/2024Q4 2023-$0.28-$0.32 -$0.04-$0.29$17.41M$19.45M      
11/8/2023Q3 2023-$0.35-$0.41 -$0.06-$0.41$5.12M$7.00M        
8/9/2023Q2 2023-$0.39-$0.70 -$0.31-$0.57$1.27M$1.50M  
This Bull Market Indicator called NVDA at $116 (Ad)

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here
5/4/2023Q1 2023-$0.37-$0.48 -$0.11-$0.48--  
3/30/2023Q4 2022-$0.30-$0.44 -$0.14-$0.44--  

Avadel Pharmaceuticals Earnings - Frequently Asked Questions

Avadel Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based off last year's report dates. Learn more on AVDL's earnings history.

In the previous quarter, Avadel Pharmaceuticals (NASDAQ:AVDL) reported ($0.03) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.06) by $0.03. Learn more on analysts' earnings estimate vs. AVDL's actual earnings.

The conference call for Avadel Pharmaceuticals's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Avadel Pharmaceuticals's latest earnings report can be read online.
Read Transcript

Avadel Pharmaceuticals (NASDAQ:AVDL) has a recorded annual revenue of $27.96 million.

Avadel Pharmaceuticals (NASDAQ:AVDL) has a recorded net income of -$160.28 million. AVDL has generated -$0.79 earnings per share over the last four quarters.

Avadel Pharmaceuticals's earnings are expected to grow from ($0.48) per share to $0.53 per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:AVDL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners